The Effect of Dual-task Training on Balance, Exercise Capacity, Cognitive Status, and Quality of Life
NCT06721429
Summary
The aim of this study is to investigate the effects of dual-task training on balance, exercise capacity, cognitive function, and quality of life in individuals with Type 2 Diabetes Mellitus (DM). As a result of this study, it is hoped that dual-task training will be an alternative to single-task training in the rehabilitation of individuals with Type 2 DM, with the goal of preventing falls and supporting a more active lifestyle. Additionally, it is intended to include dual-task training in preventive physiotherapy approaches. The main questions the study aims to answer are as follows: Is dual-task training, conducted concurrently with exercise training, more effective in improving balance when compared to exercise training alone and the control group? Is dual-task training, conducted concurrently with exercise training, more effective in improving exercise capacity, cognitive function, and quality of life when compared to exercise training alone and the control group? The researchers will compare the effects of dual-task training in individuals with Type 2 diabetes by comparing the participants in the single-task exercise training group and the control group. Participants will be randomized into the dual-task exercise training group, the single-task exercise training group, and the control group. Individuals in the training group will undergo exercise training three days a week for 8 weeks.
Eligibility
Inclusion Criteria: * Being followed up with a diagnosis of Type 2 Diabetes Mellitus for at least 6 months (fasting plasma glucose of 7.0 mmol/L or higher) * Not having participated in any structured exercise program for at least 6 months prior. * Being willing to volunteer for the study Exclusion Criteria: * Nephropathy * Retinopathy * Having dementia or Alzheimer's disease * Using a walking aid * Having ulceration * Using balance-curing drugs * Surviving myocardial infarction at least 6 months ago * Stable or unstable angina pectoris * Left ventricular ejection fraction below 40% * Peripheral arterial diseases * Resting blood pressure above 160/100 mmHg * Body mass index above 35 kg/m2 * Having a history of deep vein thrombosis, pulmonary embolism or stroke in the past
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06721429